Infertility prevalence is supporting growth in the Norditropin Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Novarel Market During The Forecast Period 2026–2030?

Historically, the growth was driven by the expansion of fertility treatment clinics, the established clinical application of hCG therapies, increasing rates of infertility diagnosis, the availability of injectable hormone formulations, and the proliferation of reproductive endocrinology practices.

Anticipated growth during the forecast period is primarily driven by the increasing embrace of sophisticated fertility solutions, the ongoing trend of rising maternal age, the broader availability of individualized fertility care plans, escalating financial commitments in reproductive healthcare, and a surge in the need for fertility treatments delivered in an outpatient setting.

Key trends identified for the forecast period encompass a heightened call for hormone-based fertility treatments, an expanding application of injectable gonadotropin medications, the wider reach of assisted reproductive technologies, a stronger emphasis on protocols for hormone level surveillance, and greater tailored clinical approaches in fertility management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20163&type=smp

Which Economic Or Industry Drivers Are Impacting The Novarel Market?

The growing incidence of infertility is projected to boost the expansion of the novarel market in the future. Infertility is defined as the inability to achieve conception after a year of consistent, unprotected sexual activity or the inability to sustain a pregnancy to full term. The increasing global rates of infertility are fueling a greater need for fertility therapies, especially ovulation induction involving hCG (like Novarel), as women look for ways to overcome issues with ovulation. Novarel assists in addressing infertility by promoting ovulation in women who struggle to release eggs and by aiding sperm production in men with insufficient testosterone, thus improving the likelihood of conception. For example, in April 2023, the World Health Organization (WHO) reported that approximately 17.5% of the adult population worldwide, roughly 1 in 6 people, encounters infertility. Consequently, the increasing occurrence of infertility is propelling the novarel market. Increased expenditure on healthcare is projected to stimulate the expansion of the novarel market moving ahead. The escalation in healthcare spending stems from factors like the growing occurrence of chronic illnesses, an aging demographic, and progress in medical innovations. This spending facilitates novarel by ensuring availability of potent infertility solutions, including the application of human chorionic gonadotropin (hCG), which aids in inducing ovulation and enhancing fertility results, thereby leading to more effective and precise care within reproductive medicine. For instance, in May 2024, a report from the UK government agency Office For National Statistics indicated that overall healthcare spending saw a 5.6% increase in nominal terms from 2022 to 2023, a significant acceleration compared to the 0.9% rise observed in 2022. Consequently, the increase in healthcare spending is propelling the novarel market.

What Market Segments Are Evaluated Within The Novarel Market?

The novarel market covered in this report is segmented –

1) By Indication: Induction Of Ovulation, Hypogonadotropic Hypogonadism, Fertility Preservation

2) By Distribution Channel: Hospital, Pharmacies, Online Pharmacies

3) By End User: Adult, Geriatric

Who Are The Top Market Participants Influencing The Novarel Market?

Major companies operating in the novarel market are Ferring Pharmaceuticals Inc.

Read the full novarel market report here:

https://www.thebusinessresearchcompany.com/report/novarel-global-market-report

What Are The Top-Performing Regions Within The Novarel Market?

North America was the largest region in the novarel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novarel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Novarel Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20163&type=smp

Browse Through More Reports Similar to the Global Novarel Market 2026, By The Business Research Company

Esg Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/esg-finance-global-market-report

Vertical Market Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/vertical-market-software-global-market-report

Automotive Silicone Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-silicone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795